Ryan J. Watts, President and CEO at Denali Therapeutics Inc. (DNLI), sold 36,666 shares at $50.44 ($1.8M) on 2021-10-01, disclosed to the SEC on 2021-10-05.
Open-market sale of $1.8M DNLI by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $49.38 | 3,304 | $163K | 8.8% |
| 2 | $49.38 | 3,304 | $163K | 8.8% |
| 3 | $50.44 | 10,782 | $544K | 29.4% |
| 4 | $50.44 | 10,782 | $544K | 29.4% |
| 5 | $50.99 | 4,247 | $217K | 11.7% |
| 6 | $50.99 | 4,247 |
| $217K |
| 11.7% |
| Total | $50.38 avg | 36,666 | $1.8M | 100% |
| Filing → |
| DNLI | SELL | 2025-01-08 | $1.5M | — | Filing → |
| DNLI | SELL | 2024-10-22 | $1.1M | — | Filing → |
| DNLI | SELL | 2024-08-22 | $108K | — | Filing → |